| This article has been cited by |
| 1 | New insight on the role of liraglutide in alleviating dexamethasone-induced pancreatic cytotoxicity via improving redox status, autophagy flux, and PI3K/Akt/Nrf2 signaling | |
| Walaa S. Elseady,Rasha A. Abd Ellatif,Remon S. Estfanous,Marwa N. Emam,Walaa A. Keshk |
| Canadian Journal of Physiology and Pharmacology.2021;99(11)1217 |
| [DOI] |
|
| 2 | COMPARATIVE STUDY OF SITAGLIPTINAND PIOGLITAZONE AS ADDONTHERAPY OVER PLASMA GLUCOSE LEVEL IN TYPE 2 DIABETES MELLITUS PATIENTS : AN OBSERVATIONAL COHORT STUDY | |
| Ravindra Kumar Das,Rahul Kumar Sinha,Debarshi Jana |
| INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2020;99(11)10 |
| [DOI] |
|
| 3 | Effect of Canagliflozin, an SGLT2 Inhibitor, in Comparison with Atorvastatin on Dexamethasone-Induced Hepatic Steatosis in Albino Rats | |
| Eman I. Ahmed,Amany M. Shaaban,Abdel Karim M. Abdel Latif |
| Current Drug Therapy.2020;15(3)274 |
| [DOI] |
|
| 4 | Protocatechuic acid exhibits hepatoprotective, vasculoprotective, antioxidant and insulin-like effects in dexamethasone-induced insulin-resistant rats | |
| Yomna A. El-Sonbaty,Ghada M. Suddek,Nirmeen Megahed,Nariman M. Gameil |
| Biochimie.2019;167(3)119 |
| [DOI] |
|
| 5 | Non-alcoholic fatty liver disease and dyslipidemia: An update | |
| Niki Katsiki,Dimitri P. Mikhailidis,Christos S. Mantzoros |
| Metabolism.2016;65(8)1109 |
| [DOI] |
|
